Urogen Pharma Ltd (URGN)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select Fields| Symbol | URGN | KMDA | GLUE | ||
| Company | Urogen Pharma Ltd | Kamada Ltd | Monte Rosa Therapeutics Inc | ||
| Price Information | |||||
| Exchange | NASDAQ | NASDAQ | NASDAQ | ||
| Open | 13.00 | 5.29 | 5.92 | ||
| High | 13.40 | 5.36 | 6.13 | ||
| Low | 12.75 | 5.26 | 5.76 | ||
| Last | 13.10 | 5.27 | 5.95 | ||
| Change | +0.26 | -0.02 | +0.03 | ||
| % Change | +2.02% | -0.38% | +0.51% | ||
| Volume | 1,201,900 | 66,400 | 141,500 | ||
| 20-Day Average Volume | 567,150 | 30,775 | 249,985 | ||
| Previous Close | 12.84 | 5.29 | 5.92 | ||
| Industry | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | ||
| Has Options | Yes | No | Yes | ||
| Technicals | |||||
| 20-Day Moving Average | 13.72 | 5.50 | 6.12 | ||
| 20-Day Raw Stochastic | 11.15% | 4.50% | 38.89% | ||
| 20-Day Relative Strength | 40.59% | 43.74% | 54.23% | ||
| Weighted Alpha | -34.55 | -3.15 | +4.15 | ||
| Today's Opinion | 88% Sell | 48% Sell | 40% Buy | ||
| Previous Opinion | 88% Sell | 40% Sell | 40% Buy | ||
| Last Month's Opinion | 24% Sell | 40% Buy | 32% Sell | ||
| Performance | |||||
| 5-Days | |||||
| %Chg | -5.14% since 09/11/24 | +0.19% since 09/11/24 | -4.34% since 09/11/24 | ||
| Low | 12.75 on 09/18/24 | 5.26 on 09/17/24 | 5.45 on 09/17/24 | ||
| High | 13.96 on 09/16/24 | 5.59 on 09/12/24 | 6.30 on 09/12/24 | ||
| 1-Month | |||||
| %Chg | -11.49% since 08/16/24 | -4.87% since 08/16/24 | +27.14% since 08/16/24 | ||
| Low | 12.75 on 09/18/24 | 5.24 on 09/09/24 | 4.60 on 08/19/24 | ||
| High | 15.89 on 08/22/24 | 5.80 on 08/29/24 | 7.05 on 08/27/24 | ||
| 3-Month | |||||
| %Chg | -22.35% since 06/18/24 | +4.15% since 06/18/24 | +68.08% since 06/18/24 | ||
| Low | 12.75 on 09/18/24 | 4.74 on 06/21/24 | 3.21 on 06/28/24 | ||
| High | 18.15 on 07/16/24 | 6.44 on 07/11/24 | 7.05 on 08/27/24 | ||
| 6-Month | |||||
| %Chg | -9.66% since 03/18/24 | -10.22% since 03/18/24 | -11.19% since 03/18/24 | ||
| Low | 10.60 on 05/13/24 | 4.74 on 06/21/24 | 3.21 on 06/28/24 | ||
| High | 20.70 on 06/14/24 | 6.44 on 07/11/24 | 8.84 on 03/26/24 | ||
| Key Statistics | |||||
| Market Capitalization, $K | 301,149 | 304,069 | 299,031 | ||
| Shares Outstanding, K | 23,454 | 57,480 | 50,512 | ||
| Annual Sales | 82,710,000 | 142,520,000 | 0 | ||
| Annual Net Income | -102,240,000 | 8,280,000 | -135,350,000 | ||
| Last Quarter Sales | 21,850,000 | 42,470,000 | 4,700,000 | ||
| Last Quarter Net Income | -33,400,000 | 4,430,000 | -30,310,000 | ||
| 60-Month Beta | 1.11 | 1.07 | 1.44 | ||
| Per-Share Information | |||||
| Most Recent Earnings | -0.91 on 08/13/24 | 0.08 on 08/14/24 | -0.43 on 08/08/24 | ||
| Latest Earnings Date | 08/13/24 | 11/11/24 | 08/08/24 | ||
| Most Recent Dividend | N/A | 0.006 on 06/13/13 | N/A | ||
| Next Ex-Dividends Date | N/A | N/A | N/A | ||
| Ratios | |||||
| Price/Earnings ttm | 0.00 | 20.22 | 0.00 | ||